| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adoptive transfer of donor B lymphocytes: a phase 1/2a study for patients after allogeneic stem cell transplantation
|
Winkler, Julia
|
|
|
8 |
10 |
p. 2373-2383
|
artikel
|
| 2 |
Amino acid supplementation confers protection to red blood cells before Plasmodium falciparum bystander stress
|
Binns, Heather Colvin
|
|
|
8 |
10 |
p. 2552-2564
|
artikel
|
| 3 |
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia
|
Hampel, Paul J.
|
|
|
8 |
10 |
p. 2342-2350
|
artikel
|
| 4 |
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia
|
Levis, Mark
|
|
|
8 |
10 |
p. 2527-2535
|
artikel
|
| 5 |
Blinatumomab consolidation for adult B-cell acute lymphoblastic leukemia in first and second complete remission
|
Urbino, Irene
|
|
|
8 |
10 |
p. 2405-2409
|
artikel
|
| 6 |
Cardiovascular events reported in patients with B-cell malignancies treated with zanubrutinib
|
Moslehi, Javid J.
|
|
|
8 |
10 |
p. 2478-2490
|
artikel
|
| 7 |
Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes
|
Chamseddine, Reem S.
|
|
|
8 |
10 |
p. 2520-2526
|
artikel
|
| 8 |
Depletion of miR-144/451 alleviates anemia in β-thalassemic mice
|
Ling, Ling
|
|
|
8 |
10 |
p. 2565-2570
|
artikel
|
| 9 |
Differentiation syndrome associated with treatment with IDH2 inhibitor enasidenib: pooled analysis from clinical trials
|
Montesinos, Pau
|
|
|
8 |
10 |
p. 2509-2519
|
artikel
|
| 10 |
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT
|
Sanz, Jaime
|
|
|
8 |
10 |
p. 2332-2341
|
artikel
|
| 11 |
Immune status and selection of patients for immunotherapy in myeloma: a proposal
|
Dhodapkar, Madhav V.
|
|
|
8 |
10 |
p. 2424-2432
|
artikel
|
| 12 |
Impact of diagnostic investigations in the management of CAR T-cell–associated neurotoxicity
|
Mauget, Matteo
|
|
|
8 |
10 |
p. 2491-2498
|
artikel
|
| 13 |
Impact of race and social determinants of health on outcomes in patients with aggressive B-cell NHL treated with CAR-T therapy
|
Karmali, Reem
|
|
|
8 |
10 |
p. 2592-2599
|
artikel
|
| 14 |
Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes
|
Yao, Chi-Yuan
|
|
|
8 |
10 |
p. 2442-2454
|
artikel
|
| 15 |
Mesenchymal stem cells: paving the way for myeloma onset?
|
Gulla, Annamaria
|
|
|
8 |
10 |
p. 2573-2574
|
artikel
|
| 16 |
Microclots, as defined by amyloid-fibrinogen aggregates, predict risks of disseminated intravascular coagulation and mortality
|
Schofield, Jeremy
|
|
|
8 |
10 |
p. 2499-2508
|
artikel
|
| 17 |
Mitapivat improves ineffective erythropoiesis and iron overload in adult patients with pyruvate kinase deficiency
|
van Beers, Eduard J.
|
|
|
8 |
10 |
p. 2433-2441
|
artikel
|
| 18 |
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes
|
Perusini, Maria Agustina
|
|
|
8 |
10 |
p. 2361-2372
|
artikel
|
| 19 |
Nivolumab plus brentuximab vedotin for relapsed/refractory peripheral T-cell lymphoma and cutaneous T-cell lymphoma
|
Zinzani, Pier Luigi
|
|
|
8 |
10 |
p. 2400-2404
|
artikel
|
| 20 |
Phillips NS, Mulrooney DA, Williams AM, et al. Neurocognitive impairment associated with chronic morbidity in long-term survivors of Hodgkin Lymphoma. Blood Adv. 2023;7(23):7270-7278.
|
|
|
|
8 |
10 |
p. 2398-2399
|
artikel
|
| 21 |
Platelet proteomic profiling in sitosterolemia suggests thrombocytopenia is driven by lipid disorder and not platelet aberrations
|
Del Castillo, Jessica
|
|
|
8 |
10 |
p. 2466-2477
|
artikel
|
| 22 |
Race and ethnicity reporting and representation in hemophilia clinical trials
|
Fedewa, Stacey A.
|
|
|
8 |
10 |
p. 2351-2360
|
artikel
|
| 23 |
Race and insurance: real-world insights on CAR-T outcomes
|
Ahmed, Nausheen
|
|
|
8 |
10 |
p. 2589-2591
|
artikel
|
| 24 |
RUNX1 C-terminal mutations impair blood cell differentiation by perturbing specific enhancer-promoter networks
|
Jayne, Nathan D.
|
|
|
8 |
10 |
p. 2410-2423
|
artikel
|
| 25 |
Selection of statistical tests considering competing risks: the importance of understanding the assumptions in each test
|
Akahoshi, Yu
|
|
|
8 |
10 |
p. 2571-2572
|
artikel
|
| 26 |
Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma
|
Bogun, Lucienne
|
|
|
8 |
10 |
p. 2575-2588
|
artikel
|
| 27 |
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy
|
Melody, Megan
|
|
|
8 |
10 |
p. 2327-2331
|
artikel
|
| 28 |
Successes and pitfalls in orphan drug development for sickle cell disease
|
Costa, Enrico
|
|
|
8 |
10 |
p. 2455-2465
|
artikel
|
| 29 |
Targeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura
|
Yada, Noritaka
|
|
|
8 |
10 |
p. 2536-2551
|
artikel
|
| 30 |
Unleashed monocytic engagement in Sézary syndrome during the combination of anti-CCR4 antibody with type I interferon
|
Jiang, Tony T.
|
|
|
8 |
10 |
p. 2384-2397
|
artikel
|
Tijdschrift beschrijving